NBIX News and Press, Neurocrine Biosciences Inc. From 01/23/24

2024-01-23 09:45:02 ET RBC Capital analyst issues UNDERPERFORM recommendation for NBIX on January 23, 2024 10:00AM ET. The previous analyst recommendation was Underperform. NBIX was trading at $140.505 at issue of the analyst recommendation. The overall analyst consensus...

2024-01-23 09:45:02 ET Wells Fargo analyst issues MARKET PERFORM recommendation for NBIX on January 23, 2024 10:00AM ET. The previous analyst recommendation was Market Perform. NBIX was trading at $140.505 at issue of the analyst recommendation. The overall analyst conse...

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2023 Financial Results PR Newswire Conference Call and Webcast Scheduled for Wednesday, February 7 SAN DIEGO , Jan. 17, 2024 /PRNewswire/ -- Neurocrine Bioscie...

2024-01-16 11:49:56 ET More on iShares Russell 1000 Growth ETF: IWF: Price Isn't Everything; Favor Growth Over Value Citi’s 30 stocks for its 2024 top themes Top overweight stocks with high growth and low volume - MS Seeking Alpha’s Quant Rating...

2024-01-04 14:57:40 ET More on SPDR S&P Biotech ETF: Biopharmaceutical Stocks: The Rally Has Just Begun Get Ready For The New Biotech Bull Market Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Biotechs p...

2024-01-03 07:00:00 ET Summary The biotech industry experienced a challenging year in 2023 due to a rising 10-year Treasury yield. In 2024, the 10-year yield should favorably support biotech stocks. Promising advancements in weight loss drugs, neuroscience, oncology, and gene ...

Neurocrine Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire SAN DIEGO , Jan. 2, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 42 nd Annual J.P. Morgan Healthcare Conference at 9:4...

2023-12-19 13:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-18 12:22:24 ET More on iShares Russell 1000 Growth ETF: IWF ETF: Be Cautious Of High Valuations Top overweight stocks with high free cash flow and EPS growth - MS Top stocks with earning stability and quality + overweight - MS Seeking Alpha’s Q...

2023-12-15 14:30:49 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips As technology advances in our era, biotechnology is not far behind. Modern day medical advancements are impressive, and the company’s making these strides have incredible results to show...